Lv4
446 积分 2020-10-30 加入
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
2个月前
已完结
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
2个月前
已完结
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice
5个月前
已完结
皖公网安备34019202002308
